Home/Filings/4/0001256928-09-000015
4//SEC Filing

ABBOTT MEDICAL OPTICS INC 4

Accession 0001256928-09-000015

CIK 0001168335operating

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 8:21 PM ET

Size

17.9 KB

Accession

0001256928-09-000015

Insider Transaction Report

Form 4
Period: 2009-02-25
Transactions
  • Disposition from Tender

    Common Stock

    2009-02-25$22.00/sh11,386$250,4920 total
  • Award

    Common Stock

    2009-02-25+3,6503,650 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh3,650$80,3000 total
  • Award

    Common Stock

    2009-02-25+6,7406,740 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh6,740$148,2800 total
  • Award

    Common Stock

    2009-02-25+2,3902,390 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh2,390$52,5800 total
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-259,5000 total
    Exercise: $33.72From: 2005-05-27Exp: 2014-05-20Common Stock (9,500 underlying)
Footnotes (3)
  • [F1]These shares were tendered to Rainforest Acquisition Inc. ("Purchaser") pursuant to Purchaser?s offer to purchase all of the outstanding shares of Advanced Medical Optics, Inc. (the "Issuer") at a cash purchase price of $22.00 per share, without interest, and subject to any required withholding taxes, subject to the terms described in the Offer to Purchase, filed with the SEC on January 27, 2009, as amended (the "Tender Offer"). Such shares were purchased by Purchaser pursuant to the Tender Offer on February 25, 2009.
  • [F2]The exempt restricted stock units (previously reported on Table II) vested in full and were settled for shares of Issuer Common Stock in accordance with the terms of the applicable equity plan. At the effective time of the merger, such shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes).
  • [F3]This previously reported exempt stock option, which has vested as to 100% of the underlying shares in accordance with its terms, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 3,897 shares of Abbott Laboratories common stock at an exercise price of $82.19 per share, determined pursuant to a formula set forth in the Merger Agreement.

Issuer

ABBOTT MEDICAL OPTICS INC

CIK 0001168335

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001168335

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 8:21 PM ET
Size
17.9 KB